Maximising Opportunities Post Coronavirus Disease 2019: Time to Embrace a New Era of Atrial Fibrillation Research

Código QR

Maximising Opportunities Post Coronavirus Disease 2019: Time to Embrace a New Era of Atrial Fibrillation Research

Guardado en:

Detalles Bibliográficos
Autor principal:	Pier D Lambiase
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/15d23308734945608933b1605c0164a3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities
por: Vishal Vyas, et al.
Publicado: (2019)

Electrophysiology in the Era of Coronavirus Disease 2019
Publicado: (2020)

Atrial Myopathy Underlying Atrial Fibrillation
por: Harold Rivner, et al.
Publicado: (2020)

Door-to-balloon Time for ST-elevation MI in the Coronavirus Disease 2019 Era
por: Haytham Mously, et al.
Publicado: (2021)

Atrial Fibrillation and Oral Health
por: Amaar Hassan, et al.
Publicado: (2021)

The Convergent Atrial Fibrillation Ablation Procedure: Evolution of a Multidisciplinary Approach to Atrial Fibrillation Management
por: Karan Wats, et al.
Publicado: (2020)

Reconceptualising Atrial Fibrillation Using Renewal Theory: A Novel Approach to the Assessment of Atrial Fibrillation Dynamics
por: Jing Xian Quah, et al.
Publicado: (2021)

Atrial Tachycardias After Atrial Fibrillation Ablation: How to Manage?
por: Yuan Hung, et al.
Publicado: (2020)

Cryoballoon Ablation of Atrial Fibrillation in Octogenarians
por: Tauseef Akhtar, et al.
Publicado: (2020)

The Next 10 Years in Atrial Fibrillation
por: Jeffrey L Turner, et al.
Publicado: (2019)

Cardiac MRI to Manage Atrial Fibrillation
por: Yan Zhao, et al.
Publicado: (2020)

Atrial Fibrillation in Congenital Heart Disease
por: Irene Martín de Miguel, et al.
Publicado: (2021)

Residual Stroke Risk in Atrial Fibrillation
por: Wern Yew Ding
Publicado: (2021)

The Cutting Edge of Atrial Fibrillation Ablation
por: Maya S Verma, et al.
Publicado: (2021)

Risk factors for recurrence of atrial fibrillation
por: Antoniya Kisheva, et al.
Publicado: (2021)

Impact of the Pattern of Atrial Fibrillation on Stroke Risk and Mortality
por: Giovanni Luca Botto, et al.
Publicado: (2021)

Rhythm Control in Heart Failure Patients with Atrial Fibrillation
por: William Eysenck, et al.
Publicado: (2020)

Atrial Fibrillation Structural Substrates: Aetiology, Identification and Implications
Publicado: (2020)

The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation
por: Agnieszka Kotalczyk, et al.
Publicado: (2021)

Identifying the key microRNAs implicated in atrial fibrillation
por: Yuejuan Cao, et al.
Publicado: (2021)

Obesity and Atrial Fibrillation: Epidemiology, Pathogenesis and Effect of Weight Loss
por: Ahmed M Al-Kaisey, et al.
Publicado: (2021)

Redefining the Standard for Atrial Fibrillation: A Patient-centric Report
por: Carina Blomström Lundqvist, et al.
Publicado: (2021)

Redefining the Standard for Atrial Fibrillation: A Patient-centric Report
por: Carina Blomström Lundqvist, et al.
Publicado: (2021)

Rivaroxaban-Associated Bullous Pemphigoid in a Patient With Atrial Fibrillation
por: Jiaming (Calvin) Liang, MD, MSc, et al.
Publicado: (2021)

Robotic surgical ablation of atrial fibrillation in mitral valve surgery
por: Ahmet Rüçhan Akar
Publicado: (2021)

Atrial Fibrillation and Dementia: Exploring the Association, Defining Risks and Improving Outcomes
por: T Jared Bunch, et al.
Publicado: (2019)

Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation
por: Dominik Linz, et al.
Publicado: (2021)

Clinical Significance of Atrial Fibrillation Status in Patients With Percutaneous Coronary Intervention
por: Toka Hamaguchi, MD, et al.
Publicado: (2021)

Hybrid Convergent Procedure for the Treatment of Persistent and Long-standing Persistent Atrial Fibrillation
por: David B DeLurgio, et al.
Publicado: (2021)

Left Ventricular Systolic Dysfunction Due to Atrial Fibrillation: Clinical and Echocardiographic Predictors
por: Erez Marcusohn, et al.
Publicado: (2021)

Mapping Technologies for Catheter Ablation of Atrial Fibrillation Beyond Pulmonary Vein Isolation
por: Giulio La Rosa, et al.
Publicado: (2021)

Carotid artery stenting, new devices and techniques for interventional cardiology and atrial fibrillation
por: Çetin Erol
Publicado: (2021)

Coronavirus Disease 2019 and Cardiac Arrhythmias
por: Antoni Martínez-Rubio, et al.
Publicado: (2020)

Coronavirus disease 2019 and flight safety
por: Sevgi Özcan
Publicado: (2021)

CHARGE-AF in a national routine primary care electronic health records database in the Netherlands: validation for 5-year risk of atrial fibrillation and implications for patient selection in atrial fibrillation screening
por: Ralf E Harskamp, et al.
Publicado: (2021)

Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart
por: Emilia D’Elia, et al.
Publicado: (2020)

Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study
por: Shahrzad Salmasi, Msc, et al.
Publicado: (2021)

Treatment of Coronavirus Disease 2019: Shooting in the Dark
por: Juan Tamargo
Publicado: (2020)

Mechanisms of Myocardial Injury in Coronavirus Disease 2019
por: Aniket S Rali, et al.
Publicado: (2020)

Early- and mid-term results of cryoablation of atrial fibrillation concomitant with robotic mitral valve surgery
por: Murat Kadan, et al.
Publicado: (2021)